CAMP4 Therapeutics Corporation: shareholders and insiders

CAMPNASDAQHealthcare · Pharmaceutical Preparations

Price

$3.79

November 20, 2026Market cap $299M

What Ploutos Investor adds for CAMP4 Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

8 Holders over 5%2 On a 13DNov 12, 2026 Latest filing
  • Janus Henderson Group
    Share of class12.2%
  • Coastlands Capital LPwith 4 more persons
    Share of class9.99%
  • 5AM Ventures VI, L.P.with 7 more persons
    Share of class9.90%
  • FMRwith 1 more person
    Share of class7.80%
  • Vivo Opportunity Fund Holdings, L.P.with 3 more persons
    Share of class7.40%
  • Adage Capital Management, L.P.with 2 more persons
    Share of class6.68%
  • Polaris Management Co. VII, L.L.C.with 7 more persons
    Share of class6.30%
  • Trails Edge Capital Partners, LPwith 2 more persons
    Share of class6.00%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Polaris Management Co. VII, L.L.C.6.3%From the filing of Sep 11, 2025

    Solely on behalf of, and only to the extent that it relates to, the Reporting Persons, Item 4 of the Original Schedule 13D is hereby amended and supplemented by the addition of the following: The Reporting Persons have previously reserved the right and continue to reserve the right, based on all relevant factors and subject to applicable law or other restrictions, at any time and from time to time, to acquire additional shares of Common Stock or other securities of the Issuer, dispose of some or all of the shares of Common Stock or other securities of the Issuer that it may own from time to time, in each case in open market or private transactions, block sales or otherwise or pursuant to…

    From the filing of Sep 11, 2025
Fell to 5% or less (5)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Balyasny Asset Management4.99%Aug 14, 202613G/A
  • Enavate Sciences GP, LLC13D4.80%Mar 11, 202613D/A
  • AH Bio Fund I, L.P.4.50%Nov 14, 202513G/A
  • Northpond Ventures II, LP4.80%Nov 14, 202513G/A
  • HarbourVest Partners L.P.2.70%Oct 1, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Millennium Mgmt (Englander)
    In the quarter-35%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 4.37% of its shares outstanding were held short, +136.4% since the report before.

Shares held short
3.45M
4.37%
Since the report before1.46M on Sep 30, 2026
+136.4%
10.1
342.9K
More days to cover thanof 4,578 US-listed companies with enough volume
91%
Report date
Oct 15, 2026
  • Oct 15, 2024: Shares held short 256.6K
  • Oct 31, 2024: Shares held short 378.7K
  • Nov 15, 2024: Shares held short 375.4K
  • Nov 29, 2024: Shares held short 405.5K
  • Dec 13, 2024: Shares held short 410.4K
  • Dec 31, 2024: Shares held short 381.0K
  • Jan 15, 2025: Shares held short 476.9K
  • Jan 31, 2025: Shares held short 285.0K
  • Feb 14, 2025: Shares held short 359.7K
  • Feb 28, 2025: Shares held short 327.9K
  • Mar 14, 2025: Shares held short 323.9K
  • Mar 31, 2025: Shares held short 348.8K
  • Apr 15, 2025: Shares held short 347.8K
  • Apr 30, 2025: Shares held short 387.1K
  • May 15, 2025: Shares held short 481.4K
  • May 30, 2025: Shares held short 491.2K
  • Jun 13, 2025: Shares held short 485.2K
  • Jun 30, 2025: Shares held short 335.3K
  • Jul 15, 2025: Shares held short 265.5K
  • Jul 31, 2025: Shares held short 247.7K
  • Aug 15, 2025: Shares held short 221.5K
  • Aug 29, 2025: Shares held short 218.5K
  • Sep 15, 2025: Shares held short 469.4K
  • Sep 30, 2025: Shares held short 352.6K
  • Oct 15, 2025: Shares held short 430.2K
  • Oct 31, 2025: Shares held short 397.7K
  • Nov 14, 2025: Shares held short 427.5K
  • Nov 28, 2025: Shares held short 416.4K
  • Dec 15, 2025: Shares held short 453.5K
  • Dec 31, 2025: Shares held short 747.3K
  • Jan 15, 2026: Shares held short 480.9K
  • Jan 30, 2026: Shares held short 537.0K
  • Feb 13, 2026: Shares held short 576.0K
  • Feb 27, 2026: Shares held short 515.1K
  • Mar 13, 2026: Shares held short 483.1K
  • Mar 31, 2026: Shares held short 414.2K
  • Apr 15, 2026: Shares held short 468.4K
  • Apr 30, 2026: Shares held short 450.5K
  • May 15, 2026: Shares held short 322.4K
  • May 29, 2026: Shares held short 340.9K
  • Jun 15, 2026: Shares held short 398.6K
  • Jun 30, 2026: Shares held short 1.31M
  • Jul 15, 2026: Shares held short 1.44M
  • Jul 31, 2026: Shares held short 1.48M
  • Aug 14, 2026: Shares held short 1.28M
  • Aug 31, 2026: Shares held short 1.19M
  • Sep 15, 2026: Shares held short 992.7K
  • Sep 30, 2026: Shares held short 1.46M
  • Oct 15, 2026: Shares held short 3.45M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading50.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 50.7% of the shares in the reported trades were short sales, against 40.2% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
50.7%
The 14 beforeOct 14, 2026 – Nov 2, 2026
40.2%
Change
+10.5 pts
Short sales a dayon average, of 55.5K shares
28.1K
More than atof 3,666 US-listed companies, same days
51%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 78.4%
  • Oct 15, 2026: Short sales 67.7%
  • Oct 16, 2026: Short sales 74.7%
  • Oct 19, 2026: Short sales 88.8%
  • Oct 20, 2026: Short sales 79.1%
  • Oct 21, 2026: Short sales 34.7%
  • Oct 22, 2026: Short sales 49.2%
  • Oct 23, 2026: Short sales 8.3%
  • Oct 26, 2026: Short sales 58.7%
  • Oct 27, 2026: Short sales 50%
  • Oct 28, 2026: Short sales 38.7%
  • Oct 29, 2026: Short sales 56.6%
  • Oct 30, 2026: Short sales 54.7%
  • Nov 2, 2026: Short sales 45.2%
  • Nov 3, 2026: Short sales 44.7%
  • Nov 4, 2026: Short sales 36.3%
  • Nov 5, 2026: Short sales 13.8%
  • Nov 6, 2026: Short sales 19.4%
  • Nov 9, 2026: Short sales 32.6%
  • Nov 10, 2026: Short sales 70.2%
  • Nov 11, 2026: Short sales 51.4%
  • Nov 12, 2026: Short sales 85.7%
  • Nov 13, 2026: Short sales 76.3%
  • Nov 16, 2026: Short sales 76.7%
  • Nov 17, 2026: Short sales 75.6%
  • Nov 18, 2026: Short sales 90.7%
  • Nov 19, 2026: Short sales 76.7%
  • Nov 20, 2026: Short sales 68.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

6 ETFs holding it0.03% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.03%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.00%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

6 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

62 Managers, Q2 2026$182M Value of their positions
  • Q3 2025: Managers 30
  • Q4 2025: Managers 41
  • Q1 2026: Managers 47
  • Q2 2026: Managers 62

Institutional investors by quarter

The fund managers holding CAMP, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 62 managers held 41.73M shares, worth $182M. During the quarter 22 opened a position, 8 closed one, 15 added and 11 trimmed.

The largest holders, Q2 2026

  • Jupiter Topco
    In the quarter
  • 5AM Venture Management
    In the quarter
  • FMR
    In the quarter-0.6%
  • Vivo Capital
    In the quarter
  • Balyasny Asset Management
    In the quarter-2.2%
  • a16z Capital Management
    In the quarter
  • Adage Capital Partners Gp
    In the quarter
  • Trails Edge Capital Partners
    In the quarter-0.3%
  • BlackRock
    In the quarter+260%
  • Vanguard Capital Management
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do CAMP4 Therapeutics's filings show?

Who buys and sells is one part of CAMP4 Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CAMP's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold CAMP?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $300.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.